Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease

Total article views   HTML views PDF downloads Totals
4,759 Dovepress* 4,313+ 852 5,165
PubMed Central* 446 142 588
Totals 4,759 994 5,753
*Since 6 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar